Tizanidne hydrochloride
- Product NDC
- 68788-7962
- 11-digit product format
- 687887962
- Labeler code
- 68788
- Product ID
- 68788-7962_d6d3b80d-b234-446b-ae35-e84366caeab4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidne Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA212196
- Marketing category
- ANDA
- Marketing start
- 2021-07-19
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 6 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7962-1 | 68788796201 | 100 CAPSULE in 1 BOTTLE (68788-7962-1) | 100 capsule | 2021-07-19 | 0000-00-00 | No | No | Current |
| 68788-7962-3 | 68788796203 | 30 CAPSULE in 1 BOTTLE (68788-7962-3) | 30 capsule | 2021-07-19 | 0000-00-00 | No | No | Current |
| 68788-7962-6 | 68788796206 | 60 CAPSULE in 1 BOTTLE (68788-7962-6) | 60 capsule | 2021-07-19 | 0000-00-00 | No | No | Current |
| 68788-7962-9 | 68788796209 | 90 CAPSULE in 1 BOTTLE (68788-7962-9) | 90 capsule | 2021-07-19 | 0000-00-00 | No | No | Current |